These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16148601)

  • 21. Haemodynamic effects of eprosartan and valsartan in hypertensive patients during isometric and mental stress.
    Arosio E; De Marchi S; Prior M; Rigoni A; Lechi A
    J Hypertens; 2005 Oct; 23(10):1923-7. PubMed ID: 16148617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker.
    Uzu T; Sakaguchi M; Yokomaku Y; Kume S; Kanasaki M; Isshiki K; Araki SI; Sugiomoto T; Koya D; Haneda M; Kashiwagi A
    Clin Exp Nephrol; 2009 Aug; 13(4):300-306. PubMed ID: 19255824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VALUE: analysis of results.
    Fretheim A
    Lancet; 2004 Sep 11-17; 364(9438):934-5; author reply 935. PubMed ID: 15364181
    [No Abstract]   [Full Text] [Related]  

  • 24. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE; Scott LJ
    Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of telmisartan vs. valsartan in the treatment of mild to moderate hypertension using ambulatory blood pressure monitoring.
    Bakris G
    J Clin Hypertens (Greenwich); 2002; 4(4 Suppl 1):26-31. PubMed ID: 12147926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun; 51(1314):47. PubMed ID: 19528888
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability.
    Ulusoy S; Ozkan G; Konca C; Kaynar K
    Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysis.
    Shigenaga A; Tamura K; Dejima T; Ozawa M; Wakui H; Masuda S; Azuma K; Tsurumi-Ikeya Y; Mitsuhashi H; Okano Y; Kokuho T; Sugano T; Ishigami T; Toya Y; Uchino K; Tokita Y; Umemura S
    Nephron Clin Pract; 2009; 112(1):c31-40. PubMed ID: 19342867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sartans for hypertension--implications of the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial.
    Cheung BM
    Hong Kong Med J; 2004 Oct; 10(5):359. PubMed ID: 15479968
    [No Abstract]   [Full Text] [Related]  

  • 30. [AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
    MMW Fortschr Med; 2003 Apr; 145(15):62. PubMed ID: 15104271
    [No Abstract]   [Full Text] [Related]  

  • 31. The angiotensin receptor antagonist valsartan: a review of the literature with a focus on clinical trials.
    Mistry NB; Westheim AS; Kjeldsen SE
    Expert Opin Pharmacother; 2006 Apr; 7(5):575-81. PubMed ID: 16553573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension.
    White WB; Weber MA; Sica D; Bakris GL; Perez A; Cao C; Kupfer S
    Hypertension; 2011 Mar; 57(3):413-20. PubMed ID: 21282560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Telmisartan or valsartan alone or in combination with hydrochlorothiazide: a review.
    Lacourcière Y
    Clin Exp Hypertens; 2013; 35(1):50-60. PubMed ID: 22866964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Despite drug treatment, ever second hypertensive patient with morning blood pressure too high].
    MMW Fortschr Med; 2004 Aug; 146(33-34):52. PubMed ID: 15526635
    [No Abstract]   [Full Text] [Related]  

  • 35. Valsartan treatment of hypertension--does VALUE add value?
    Lindholm LH
    Lancet; 2004 Jun; 363(9426):2010-1. PubMed ID: 15207946
    [No Abstract]   [Full Text] [Related]  

  • 36. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
    MMW Fortschr Med; 2007 Nov; 149(46):52-3. PubMed ID: 18069195
    [No Abstract]   [Full Text] [Related]  

  • 37. Val-HeFT: do angiotensin-receptor blockers benefit heart failure patients already receiving ACE inhibitor therapy?
    McMurray JJ
    Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):128-9. PubMed ID: 16265452
    [No Abstract]   [Full Text] [Related]  

  • 38. Valsartan plus hydrochlorothiazide: a review of its use since its introduction.
    Bains J; Smith WB
    Expert Opin Pharmacother; 2011 Aug; 12(12):1975-84. PubMed ID: 21728903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The value of VALUE--a hypertension study which compared valsartan with amlodipine. New data support early, optimal blood pressure control for high-risk patients].
    Nilsson PM
    Lakartidningen; 2004 Jul; 101(30-31):2426-7. PubMed ID: 15314941
    [No Abstract]   [Full Text] [Related]  

  • 40. [Medical and social implications of sexual dysfunction and safety of antihypertensive therapy in hypertensive patients].
    Vertkin AL; Vilkovyskiĭ FA; Skotnikov AS; Zviagintseva EI; Skotnikova EV
    Kardiologiia; 2011; 51(10):46-52. PubMed ID: 22117681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.